Flavonoids in atherosclerosis: An overview of their mechanisms of action

Current Medicinal Chemistry

Volumn 20, Issue 21, 2013, Pages 2641-2660

  Siasos, G ^a   Tousoulis, D ^a   Tsigkou, V ^a   Kokkou, E ^a   Oikonomou, E ^a   Vavuranakis, M ^a   Basdra, E K ^a   Papavassiliou, A G ^a   Stefanadis, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antioxidants; Atheroscierosis; Cardiovascular disease; Flavonoids; Inflammation

Indexed keywords

ANTHOCYANIN; ATORVASTATIN; BIOLOGICAL MARKER; CATECHIN; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONOID; ISOFLAVONE DERIVATIVE; LIPID; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; COLON FLORA; CONJUGATION; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG ELIMINATION; DRUG METABOLISM; DRUG SAFETY; DRUG TRANSPORT; DRUG UPTAKE; ENVIRONMENTAL FACTOR; GLYCOSYLATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RED WINE; REGULATORY MECHANISM; REVIEW; VASODILATATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHEROSCLEROSIS; DISEASE PROGRESSION; FLAVONOIDS; HUMANS; OXIDATIVE STRESS;

EID: 84880286634     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320210003     Document Type: Review

References (307)

1. Kondratyuk TP., Pezzutto, J. M. Natural Product Polyphenols of Relevance to Human Health. Pharm. Biol., 2004, 42, 46-63.
2. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79 (5), 727-747.
3. Grassi, D.; Desideri, G.; Croce, G.; Tiberti, S.; Aggio, A.; Ferri, C. Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Des., 2009, 15 (10), 1072-1084.
4. Scalbert, A.; Manach, C.; Morand, C.; Remesy, C.; Jimenez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr., 2005, 45 (4), 287-306.
5. Scalbert, A.; Johnson, I. T.; Saltmarsh, M. Polyphenols: Antioxidants and beyond. Am. J. Clin. Nutr., 2005, 81 (1 Suppl), 215S-217S.
6. Chen, Y. T.; Zheng, R. L.; Jia, Z. J.; Ju, Y. Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med., 1990, 9 (1), 19-21.
7. Russo, A.; Acquaviva, R.; Campisi, A.; Sorrenti, V.; Di Giacomo, C.; Virgata, G.; Barcellona, M. L.; Vanella, A. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biol. Toxicol., 2000, 16 (2), 91-98.
8. Middleton, E., Jr.; Kandaswami, C.; Theoharides, T. C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000, 52 (4), 673-751.
9. Timberlake, C. F.; Henry, B. S. Plant pigments as natural food colours. Endeavour, 1986, 10 (1), 31-36.
10. Clifford, M. N. Anthocyanins - nature, occurrence and dietary burden. J. Food Sci. Agric., 2000, 80 (7), 1063-1072.
11. Price, S. F., Breen, P J, Valladao M, Watson BT. Cluster sun exposure and quercetin in Pinot noir grapes and wine. Am. J. Enol. Vitiv., 1995, 46, 187-194.
12. Soleas, G. J.; Diamandis, E. P.; Goldberg, D. M. Wine as a biological fluid: History, production, and role in disease prevention. J. Clin. Lab. Anal., 1997, 11 (5), 287-313.
13. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov., 2006, 5 (6), 493-506.
14. Reinli, K.; Block, G. Phytoestrogen content of foods-A compendium of literature values. Nutr. Cancer, 1996, 26 (2), 123-148.
15. Balentine, D. A.; Wiseman, S. A.; Bouwens, L. C. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr., 1997, 37 (8), 693-704.
16. Dufresne, C. J.; Farnworth, E. R. A review of latest research findings on the health promotion properties of tea. J. Nutr. Biochem., 2001, 12 (7), 404-421.
17. Higdon, J. V.; Frei, B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr., 2003, 43 (1), 89-143.
18. Mukhtar, H.; Ahmad, N. Tea polyphenols: Prevention of cancer and optimizing health. Am. J. Clin. Nutr., 2000, 71 (6 Suppl), 1698S-1702S; discussion 1703S-1694S.
19. Khan, N.; Mukhtar, H. Tea polyphenols for health promotion. Life Sci., 2007, 81 (7), 519-533.
20. Rice-Evans, C. A.; Miller, N. J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 1996, 20 (7), 933-956.
21. Beecher, G. R. Overview of dietary flavonoids: Nomenclature, occurrence and intake. J. Nutr., 2003, 133 (10), 3248S-3254S.
22. Sandos-Buelga C. S. A. Proanthocyanidins and tannin-like compounds: Nature, occurrence, dietary intake and effects on nutrition and health. J. Sci. Food Agric., 2000, 80 (1094-1117).
23. Chalker-Scott L. Environmental significance of anthocyanins in plant stress responses. Photochem. Photobiol., 1999, 70, 1-9.
24. Hertog, M. G.; Hollman, P. C.; Katan, M. B.; Kromhout, D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer, 1993, 20 (1), 21-29.
25. Asami, D. K.; Hong, Y. J.; Barrett, D. M.; Mitchell, A. E. Comparison of the total phenolic and ascorbic acid content of freeze-dried and air-dried marionberry, strawberry, and corn grown using conventional, organic, and sustainable agricultural practices. J. Agric. Food Chem., 2003, 51 (5), 1237-1241.
26. Kuhnau, J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev. Nutr. Diet, 1976, 24, 117-191.
27. Sampson, L.; Rimm, E.; Hollman, P. C.; de Vries, J. H.; Katan, M. B. Flavonol and flavone intakes in US health professionals. J. Am. Diet Assoc., 2002, 102 (10), 1414-1420.
28. Kimira, M.; Arai, Y.; Shimoi, K.; Watanabe, S. Japanese intake of flavonoids and isoflavonoids from foods. J. Epidemiol., 1998, 8 (3), 168-175.
29. Pascual-Teresa S. Analisis de taninos condensados en alimentos. [Analysis of condensed tannins in food.]. Salamanca, 1999.
30. Chun, O. K.; Chung, S. J.; Song, W. O. Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr., 2007, 137 (5), 1244-1252.
31. Egert, S.; Rimbach, G. Which sources of flavonoids: Complex diets or dietary supplements? Adv. Nutr., 2011, 2 (1), 8-14.
32. Hurt, R. T.; Wilson, T. Geriatric obesity: Evaluating the evidence for the use of flavonoids to promote weight loss. J. Nutr. Gerontol. Geriatr., 2012, 31 (3), 269-289.
33. Gee, J. M.; DuPont, M. S.; Rhodes, M. J.; Johnson, I. T. Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radic. Biol. Med., 1998, 25 (1), 19-25.
34. Day, A. J.; DuPont, M. S.; Ridley, S.; Rhodes, M.; Rhodes, M. J.; Morgan, M. R.; Williamson, G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver betaglucosidase activity. FEBS Lett., 1998, 436 (1), 71-75.
35. Halliwell, B.; Zhao, K.; Whiteman, M. The gastrointestinal tract: A major site of antioxidant action? Free Radic. Res., 2000, 33 (6), 819-830.
36. Serafini, M.; Ghiselli, A.; Ferro-Luzzi, A. In vivo antioxidant effect of green and black tea in man. Eur. J. Clin. Nutr., 1996, 50 (1), 28-32.
37. Kim, D. H.; Jung, E. A.; Sohng, I. S.; Han, J. A.; Kim, T. H.; Han, M. J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res., 1998, 21 (1), 17-23.
38. Setchell, K. D.; Brown, N. M.; Lydeking-Olsen, E. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr., 2002, 132 (12), 3577-3584.
39. Tilgmann, C.; Ulmanen, I. Purification methods of mammalian catechol-O-methyltransferases. J. Chromatogr. B. Biomed. Appl., 1996, 684 (1-2), 147-161.
40. Falany, C. N. Enzymology of human cytosolic sulfotransferases. FASEB J., 1997, 11 (4), 206-216.
41. Boersma, M. G.; van der Woude, H.; Bogaards, J.; Boeren, S.; Vervoort, J.; Cnubben, N. H.; van Iersel, M. L.; van Bladeren, P. J.; Rietjens, I. M. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem. Res. Toxicol., 2002, 15 (5), 662-670.
42. Fukumoto, L. R.; Mazza, G. Assessing antioxidant and prooxidant activities of phenolic compounds. J. Agric. Food Chem., 2000, 48 (8), 3597-3604.
43. Day, A. J.; Bao, Y.; Morgan, M. R.; Williamson, G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic. Biol. Med., 2000, 29 (12), 1234-1243.
44. Yang, J. H.; Hsia, T. C.; Kuo, H. M.; Chao, P. D.; Chou, C. C.; Wei, Y. H.; Chung, J. G. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab. Dispos., 2006, 34 (2), 296-304.
45. Yoshizumi, M.; Tsuchiya, K.; Suzaki, Y.; Kirima, K.; Kyaw, M.; Moon, J. H.; Terao, J.; Tamaki, T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem. Biophys. Res. Commun., 2002, 293 (5), 1458-1465.
46. O'Leary, K. A.; de Pascual-Tereasa, S.; Needs, P. W.; Bao, Y. P.; O'Brien, N. M.; Williamson, G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat. Res., 2004, 551 (1-2), 245-254.
47. Boulton, D. W.; Walle, U. K.; Walle, T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J. Pharm. Pharmacol., 1998, 50 (2), 243-249.
48. Verstraeten, S. V.; Keen, C. L.; Schmitz, H. H.; Fraga, C. G.; Oteiza, P. I. Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic. Biol. Med., 2003, 34 (1), 84-92.
49. Gimeno, E.; Fito, M.; Lamuela-Raventos, R. M.; Castellote, A. I.; Covas, M.; Farre, M.; de La Torre-Boronat, M. C.; Lopez-Sabater, M. C. Effect of ingestion of virgin olive oil on human low-density lipoprotein composition. Eur. J. Clin. Nutr., 2002, 56 (2), 114-120.
50. Hollman, P. C.; van Trijp, J. M.; Buysman, M. N.; van der Gaag, M. S.; Mengelers, M. J.; de Vries, J. H.; Katan, M. B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett., 1997, 418 (1-2), 152-156.
51. Ueno, I.; Nakano, N.; Hirono, I. Metabolic fate of [14C] quercetin in the ACI rat. Jpn. J. Ex.p Med., 1983, 53 (1), 41-50.
52. Abd El Mohsen, M. M.; Kuhnle, G.; Rechner, A. R.; Schroeter, H.; Rose, S.; Jenner, P.; Rice-Evans, C. A. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic. Biol. Med., 2002, 33 (12), 1693-1702.
53. Youdim, K. A.; Martin, A.; Joseph, J. A. Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic. Biol. Med., 2000, 29 (1), 51-60.
54. Kim, S.; Lee, M. J.; Hong, J.; Li, C.; Smith, T. J.; Yang, G. Y.; Seril, D. N.; Yang, C. S. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer, 2000, 37 (1), 41-48.
55. Lee, Y. S.; Reidenberg, M. M. A method for measuring naringenin in biological fluids and its disposition from grapefruit juice by man. Pharmacology, 1998, 56 (6), 314-317.
56. Fuhr, U.; Kummert, A. L. The fate of naringin in humans: A key to grapefruit juice-drug interactions? Clin. Pharmacol. Ther., 1995, 58 (4), 365-373.
57. Setchell, K. D.; Faughnan, M. S.; Avades, T.; Zimmer-Nechemias, L.; Brown, N. M.; Wolfe, B. E.; Brashear, W. T.; Desai, P.; Oldfield, M. F.; Botting, N. P.; Cassidy, A. Comparing the pharmacokinetics of daidzein and genistein with the use of 13Clabeled tracers in premenopausal women. Am. J. Clin. Nutr., 2003, 77 (2), 411-419.
58. Bub, A.; Watzl, B.; Heeb, D.; Rechkemmer, G.; Briviba, K. Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice. Eur. J. Nutr., 2001, 40 (3), 113-120.
59. Hider, R. C.; Liu, Z. D.; Khodr, H. H. Metal chelation of polyphenols. Methods Enzymol., 2001, 335, 190-203.
60. Ma, Q.; Kim, E. Y.; Han, O. Bioactive dietary polyphenols decrease heme iron absorption by decreasing basolateral iron release in human intestinal Caco-2 cells. J. Nutr., 2010, 140 (6), 1117-1121.
61. Zijp, I. M.; Korver, O.; Tijburg, L. B. Effect of tea and other dietary factors on iron absorption. Crit. Rev. Food Sci. Nutr., 2000, 40 (5), 371-398.
62. Frejnagel, S.; Wroblewska, M. Comparative effect of green tea, chokeberry and honeysuckle polyphenols on nutrients and mineral absorption and digestibility in rats. Ann. Nutr. Metab., 2010, 56 (3), 163-169.
63. Record, I. R.; McInerney, J. K.; Dreosti, I. E. Black tea, green tea, and tea polyphenols. Effects on trace element status in weanling rats. Biol. Trace Elem. Res., 1996, 53 (1-3), 27-43.
64. Doerge, D. R.; Sheehan, D. M. Goitrogenic and estrogenic activity of soy isoflavones. Environ. Health Perspect., 2002, 110 Suppl 3, 349-353.
65. Cermak, R.; Wein, S.; Wolffram, S.; Langguth, P. Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs. Eur. J. Pharm. Sci., 2009, 38 (5), 519-524.
66. Rendic, S. Summary of information on human CYP enzymes: Human P450 metabolism data. Drug Metab. Rev., 2002, 34 (1-2), 83-448.
67. Zikria, J.; Goldman, R.; Ansell, J. Cranberry juice and warfarin: When bad publicity trumps science. Am. J. Med., 2010, 123 (5), 384-392.
68. Raza, H.; John, A. Green tea polyphenol epigallocatechin-3-gallate differentially modulates oxidative stress in PC12 cell compartments. Toxicol. Appl. Pharmacol., 2005, 207 (3), 212-220.
69. Rubio, A. R.; Morales-Segura, M. A. Nitric oxide, an iceberg in cardiovascular physiology: Far beyond vessel tone control. Arch. Med. Res., 2004, 35 (1), 1-11.
70. Holt, R. R.; Lazarus, S. A.; Sullards, M. C.; Zhu, Q. Y.; Schramm, D. D.; Hammerstone, J. F.; Fraga, C. G.; Schmitz, H. H.; Keen, C. L. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr., 2002, 76 (4), 798-804.
71. Williams, R. J.; Spencer, J. P.; Rice-Evans, C. Flavonoids: Antioxidants or signalling molecules? Free Radic. Biol. Med., 2004, 36 (7), 838-849.
72. Schewe, T.; Steffen, Y.; Sies, H. How do dietary flavanols improve vascular function? A position paper. Arch. Biochem. Biophys., 2008, 476 (2), 102-106.
73. Croft, K. D. The chemistry and biological effects of flavonoids and phenolic acids. Ann. N. Y. Acad. Sci., 1998, 854, 435-442.
74. Okawa, M.; Kinjo, J.; Nohara, T.; Ono, M. DPPH (1,1-diphenyl-2- picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants. Biol. Pharm. Bull., 2001, 24 (10), 1202-1205.
75. Firuzi, O.; Mladenka, P.; Petrucci, R.; Marrosu, G.; Saso, L. Hypochlorite scavenging activity of flavonoids. J. Pharm. Pharmacol., 2004, 56 (6), 801-807.
76. Shiba, Y.; Kinoshita, T.; Chuman, H.; Taketani, Y.; Takeda, E.; Kato, Y.; Naito, M.; Kawabata, K.; Ishisaka, A.; Terao, J.; Kawai, Y. Flavonoids as substrates and inhibitors of myeloperoxidase: Molecular actions of aglycone and metabolites. Chem. Res. Toxicol., 2008, 21 (8), 1600-1609.
77. Chang, W. T.; Shao, Z. H.; Yin, J. J.; Mehendale, S.; Wang, C. Z.; Qin, Y.; Li, J.; Chen, W. J.; Chien, C. T.; Becker, L. B.; Vanden Hoek, T. L.; Yuan, C. S. Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur. J. Pharmacol., 2007, 566 (1-3), 58-66.
78. Afanas'ev, I. B.; Dorozhko, A. I.; Brodskii, A. V.; Kostyuk, V. A.; Potapovitch, A. I. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol., 1989, 38 (11), 1763-1769.
79. Loke, W. M.; Proudfoot, J. M.; Stewart, S.; McKinley, A. J.; Needs, P. W.; Kroon, P. A.; Hodgson, J. M.; Croft, K. D. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: Lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem. Pharmacol., 2008, 75 (5), 1045-1053.
80. Schweigert, N.; Zehnder, A. J.; Eggen, R. I. Chemical properties of catechols and their molecular modes of toxic action in cells, from microorganisms to mammals. Environ. Microbiol., 2001, 3 (2), 81-91.
81. Sestili, P.; Diamantini, G.; Bedini, A.; Cerioni, L.; Tommasini, I.; Tarzia, G.; Cantoni, O. Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tertbutylhydroperoxide via an iron-chelating mechanism. Biochem. J., 2002, 364 (Pt 1), 121-128.
82. Steffen, Y.; Schewe, T.; Sies, H. (-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem. Biophys. Res. Commun., 2007, 359 (3), 828-833.
83. Park, Y. C.; Rimbach, G.; Saliou, C.; Valacchi, G.; Packer, L. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett., 2000, 465 (2-3), 93-97.
84. Cos, P.; Ying, L.; Calomme, M.; Hu, J. P.; Cimanga, K.; Van Poel, B.; Pieters, L.; Vlietinck, A. J.; Vanden Berghe, D. Structureactivity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod., 1998, 61 (1), 71-76.
85. Costantino, L.; Rastelli, G.; Albasini, A. Anthocyanidines as inhibitors of xanthine oxidase. Pharmazie, 1995, 50 (8), 573-574.
86. Ozyurek, M.; Bektasoglu, B.; Guclu, K.; Apak, R. Measurement of xanthine oxidase inhibition activity of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method. Anal. Chim. Acta, 2009, 636 (1), 42-50.
87. Frei, B.; Higdon, J. V. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J. Nutr., 2003, 133 (10), 3275S-3284S.
88. Babu, P. V.; Sabitha, K. E.; Shyamaladevi, C. S. Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chem. Biol. Interact., 2006, 162 (2), 114-120.
89. Sur-Altiner, D.; Yenice, B. Effect of black tea on lipid peroxidation in carbon tetrachloride treated male rats. Drug Metabol. Drug Interact., 2000, 16 (2), 123-128.
90. Stangl, V.; Lorenz, M.; Stangl, K. The role of tea and tea flavonoids in cardiovascular health. Mol. Nutr. Food Res., 2006, 50 (2), 218-228.
91. Ishikawa, T.; Suzukawa, M.; Ito, T.; Yoshida, H.; Ayaori, M.; Nishiwaki, M.; Yonemura, A.; Hara, Y.; Nakamura, H. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr., 1997, 66 (2), 261-266.
92. Yamanaka, N.; Oda, O.; Nagao, S. Green tea catechins such as (-)-epicatechin and (-)-epigallocatechin accelerate Cu2+-induced low density lipoprotein oxidation in propagation phase. FEBS Lett., 1997, 401 (2-3), 230-234.
93. Mann, G. E.; Niehueser-Saran, J.; Watson, A.; Gao, L.; Ishii, T.; de Winter, P.; Siow, R. C. Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: Implications for atherosclerosis and preeclampsia. Sheng Li Xue Bao, 2007, 59 (2), 117-127.
94. Rahman, I.; Biswas, S. K.; Kirkham, P. A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol., 2006, 72 (11), 1439-1452.
95. Annadurai, T.; Muralidharan, A. R.; Joseph, T.; Hsu, M. J.; Thomas, P. A.; Geraldine, P. Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamideinduced experimental diabetic rats. J. Physiol. Biochem., 2012, 68 (3), 307-318.
96. Masella, R.; Di Benedetto, R.; Vari, R.; Filesi, C.; Giovannini, C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem., 2005, 16 (10), 577-586.
97. Mann, G. E.; Rowlands, D. J.; Li, F. Y.; de Winter, P.; Siow, R. C. Activation of endothelial nitric oxide synthase by dietary isoflavones: Role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc. Res., 2007, 75 (2), 261-274.
98. Mackenzie, G. G.; Carrasquedo, F.; Delfino, J. M.; Keen, C. L.; Fraga, C. G.; Oteiza, P. I. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J., 2004, 18 (1), 167-169.
99. Erlejman, A. G.; Jaggers, G.; Fraga, C. G.; Oteiza, P. I. TNFalphainduced NF-kappaB activation and cell oxidant production are modulated by hexameric procyanidins in Caco-2 cells. Arch. Biochem. Biophys., 2008, 476 (2), 186-195.
100. Ha, S. K.; Lee, P.; Park, J. A.; Oh, H. R.; Lee, S. Y.; Park, J. H.; Lee, E. H.; Ryu, J. H.; Lee, K. R.; Kim, S. Y. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem. Int., 2008, 52 (4-5), 878-886.
101. Sobottka, A. M.; Werner, W.; Blaschke, G.; Kiefer, W.; Nowe, U.; Dannhardt, G.; Schapoval, E. E.; Schenkel, E. P.; Scriba, G. K. Effect of flavonol derivatives on the carrageenin-induced paw edema in the rat and inhibition of cyclooxygenase-1 and 5-lipoxygenase in vitro. Arch. Pharm. (Weinheim), 2000, 333 (7), 205-210.
102. Welton, A. F.; Tobias, L. D.; Fiedler-Nagy, C.; Anderson, W.; Hope, W.; Meyers, K.; Coffey, J. W. Effect of flavonoids on arachidonic acid metabolism. Prog Clin. Biol. Res., 1986, 213, 231-242.
103. Liang, Y. C.; Huang, Y. T.; Tsai, S. H.; Lin-Shiau, S. Y.; Chen, C. F.; Lin, J. K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis, 1999, 20 (10), 1945-1952.
104. Sakata, K.; Hirose, Y.; Qiao, Z.; Tanaka, T.; Mori, H. Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Lett., 2003, 199 (2), 139-145.
105. Kim, H. K.; Cheon, B. S.; Kim, Y. H.; Kim, S. Y.; Kim, H. P. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem. Pharmacol., 1999, 58 (5), 759-765.
106. Raso, G. M.; Meli, R.; Di Carlo, G.; Pacilio, M.; Di Carlo, R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci., 2001, 68 (8), 921-931.
107. Hiermann, A.; Schramm, H. W.; Laufer, S. Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related compounds. Inflamm. Res., 1998, 47 (11), 421-427.
108. Al-Fayez, M.; Cai, H.; Tunstall, R.; Steward, W. P.; Gescher, A. J. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin. Cancer Chemother. Pharmacol., 2006, 58 (6), 816-825.
109. Santangelo, C.; Vari, R.; Scazzocchio, B.; Di Benedetto, R.; Filesi, C.; Masella, R. Polyphenols, intracellular signalling and inflammation. Ann. Ist. Super. Sanita, 2007, 43 (4), 394-405.
110. Geng, Y.; Zhang, B.; Lotz, M. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol., 1993, 151 (12), 6692-6700.
111. Coskun, O.; Kanter, M.; Korkmaz, A.; Oter, S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol. Res., 2005, 51 (2), 117-123.
112. Kim, M. J.; Ryu, G. R.; Chung, J. S.; Sim, S. S.; Min, D. S.; Rhie, D. J.; Yoon, S. H.; Hahn, S. J.; Kim, M. S.; Jo, Y. H. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: In vivo and in vitro. Pancreas, 2003, 26 (3), 292-299.
113. Wadsworth, T. L.; McDonald, T. L.; Koop, D. R. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharideinduced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem. Pharmacol., 2001, 62 (7), 963-974.
114. Ruiz, P. A.; Braune, A.; Holzlwimmer, G.; Quintanilla-Fend, L.; Haller, D. Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J. Nutr., 2007, 137 (5), 1208-1215.
115. Muller, J. M.; Rupec, R. A.; Baeuerle, P. A. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods, 1997, 11 (3), 301-312.
116. Jobin, C.; Bradham, C. A.; Russo, M. P.; Juma, B.; Narula, A. S.; Brenner, D. A.; Sartor, R. B. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J. Immunol., 1999, 163 (6), 3474-3483.
117. Badia, E.; Sacanella, E.; Fernandez-Sola, J.; Nicolas, J. M.; Antunez, E.; Rotilio, D.; de Gaetano, G.; Urbano-Marquez, A.; Estruch, R. Decreased tumor necrosis factor-induced adhesion of human monocytes to endothelial cells after moderate alcohol consumption. Am. J. Clin. Nutr., 2004, 80 (1), 225-230.
118. Lotito, S. B.; Frei, B. Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. J. Biol. Chem., 2006, 281 (48), 37102-37110.
119. Crespo, I.; Garcia-Mediavilla, M. V.; Gutierrez, B.; Sanchez-Campos, S.; Tunon, M. J.; Gonzalez-Gallego, J. A comparison of the effects of kaempferol and quercetin on cytokine-induced proinflammatory status of cultured human endothelial cells. Br. J. Nutr., 2008, 100 (5), 968-976.
120. Gerritsen, M. E.; Carley, W. W.; Ranges, G. E.; Shen, C. P.; Phan, S. A.; Ligon, G. F.; Perry, C. A. Flavonoids inhibit cytokineinduced endothelial cell adhesion protein gene expression. Am. J. Pathol., 1995, 147 (2), 278-292.
121. Kobuchi, H.; Roy, S.; Sen, C. K.; Nguyen, H. G.; Packer, L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am. J. Physiol., 1999, 277 (3 Pt 1), C403-411.
122. Cho, S. Y.; Park, S. J.; Kwon, M. J.; Jeong, T. S.; Bok, S. H.; Choi, W. Y.; Jeong, W. I.; Ryu, S. Y.; Do, S. H.; Lee, C. S.; Song, J. C.; Jeong, K. S. Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol. Cell Biochem., 2003, 243 (1-2), 153-160.
123. Chen, X. L.; Dodd, G.; Thomas, S.; Zhang, X.; Wasserman, M. A.; Rovin, B. H.; Kunsch, C. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. Heart Circ. Physiol., 2006, 290 (5), H1862-1870.
124. Guerrero, J. A.; Lozano, M. L.; Castillo, J.; Benavente-Garcia, O.; Vicente, V.; Rivera, J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J. Thromb. Haemost., 2005, 3 (2), 369-376.
125. Navarro-Nunez, L.; Castillo, J.; Lozano, M. L.; Martinez, C.; Benavente-Garcia, O.; Vicente, V.; Rivera, J. Thromboxane A2 receptor antagonism by flavonoids: Structure-activity relationships. J. Agric. Food Chem., 2009, 57 (4), 1589-1594.\
126. Nakashima, S.; Koike, T.; Nozawa, Y. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Mol. Pharmacol., 1991, 39 (4), 475-480.
127. de Graaf, J. C.; Banga, J. D.; Moncada, S.; Palmer, R. M.; de Groot, P. G.; Sixma, J. J. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation, 1992, 85 (6), 2284-2290.
128. Pignatelli, P.; Pulcinelli, F. M.; Celestini, A.; Lenti, L.; Ghiselli, A.; Gazzaniga, P. P.; Violi, F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am. J. Clin. Nutr., 2000, 72 (5), 1150-1155.
129. Peluso, M. R.; Winters, T. A.; Shanahan, M. F.; Banz, W. J. A cooperative interaction between soy protein and its isoflavoneenriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J. Nutr., 2000, 130 (9), 2333-2342.
130. de Lange, D. W.; Verhoef, S.; Gorter, G.; Kraaijenhagen, R. J.; van de Wiel, A.; Akkerman, J. W. Polyphenolic grape extract inhibits platelet activation through PECAM-1: An explanation for the French paradox. Alcohol. Clin. Exp. Res., 2007, 31 (8), 1308-1314.
131. Horstman, L. L.; Ahn, Y. S. Platelet microparticles: A wide-angle perspective. Crit. Rev. Oncol. Hematol., 1999, 30 (2), 111-142.
132. Preston, R. A.; Jy, W.; Jimenez, J. J.; Mauro, L. M.; Horstman, L. L.; Valle, M.; Aime, G.; Ahn, Y. S. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension, 2003, 41 (2), 211-217.
133. Keevil, J. G.; Osman, H. E.; Reed, J. D.; Folts, J. D. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J. Nutr., 2000, 130 (1), 53-56.
134. Osman, H. E.; Maalej, N.; Shanmuganayagam, D.; Folts, J. D. Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys. J. Nutr., 1998, 128 (12), 2307-2312.
135. Sugatani, J.; Fukazawa, N.; Ujihara, K.; Yoshinari, K.; Abe, I.; Noguchi, H.; Miwa, M. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3- phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. Int. Arch. Allergy Immunol., 2004, 134 (1), 17-28.
136. Landolfi, R.; Mower, R. L.; Steiner, M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem. Pharmacol., 1984, 33 (9), 1525-1530.
137. Hubbard, G. P.; Stevens, J. M.; Cicmil, M.; Sage, T.; Jordan, P. A.; Williams, C. M.; Lovegrove, J. A.; Gibbins, J. M. Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J. Thromb. Haemost., 2003, 1 (5), 1079-1088.
138. Freedman, J. E.; Parker, C., 3rd; Li, L.; Perlman, J. A.; Frei, B.; Ivanov, V.; Deak, L. R.; Iafrati, M. D.; Folts, J. D. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation, 2001, 103 (23), 2792-2798.
139. Arts, I. C.; Hollman, P. C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr., 2005, 81 (1 Suppl), 317S-325S.
140. Stoclet, J. C.; Kleschyov, A.; Andriambeloson, E.; Diebolt, M.; Andriantsitohaina, R. Endothelial no release caused by red wine polyphenols. J. Physiol. Pharmacol., 1999, 50 (4), 535-540.
141. Perez-Vizcaino, F.; Duarte, J.; Andriantsitohaina, R. Endothelial function and cardiovascular disease: Effects of quercetin and wine polyphenols. Free Radic. Res., 2006, 40 (10), 1054-1065.
142. Carini, M.; Aldini, G.; Bombardelli, E.; Morazzoni, P.; Maffei Facino, R. UVB-induced hemolysis of rat erythrocytes: Protective effect of procyanidins from grape seeds. Life Sci., 2000, 67 (15), 1799-1814.
143. Martin, S.; Andriambeloson, E.; Takeda, K.; Andriantsitohaina, R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: A basis to elucidate signalling pathways leading to nitric oxide production. Br. J. Pharmacol., 2002, 135 (6), 1579-1587.
144. Andriambeloson, E.; Kleschyov, A. L.; Muller, B.; Beretz, A.; Stoclet, J. C.; Andriantsitohaina, R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br. J. Pharmacol., 1997, 120 (6), 1053-1058.
145. Chen, Z. Y.; Zhang, Z. S.; Kwan, K. Y.; Zhu, M.; Ho, W. K.; Huang, Y. Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci., 1998, 63 (22), 1983-1991.
146. Duarte, J.; Jimenez, R.; Villar, I. C.; Perez-Vizcaino, F.; Jimenez, J.; Tamargo, J. Vasorelaxant effects of the bioflavonoid chrysin in isolated rat aorta. Planta Med., 2001, 67 (6), 567-569.
147. Fitzpatrick, D. F.; Hirschfield, S. L.; Ricci, T.; Jantzen, P.; Coffey, R. G. Endothelium-dependent vasorelaxation caused by various plant extracts. J. Cardiovasc. Pharmacol., 1995, 26 (1), 90-95.
148. Flesch, M.; Schwarz, A.; Bohm, M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am. J. Physiol., 1998, 275 (4 Pt 2), H1183-1190.
149. Lorenz, M.; Wessler, S.; Follmann, E.; Michaelis, W.; Dusterhoft, T.; Baumann, G.; Stangl, K.; Stangl, V. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMPdependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J. Biol. Chem., 2004, 279 (7), 6190-6195.
150. Anter, E.; Thomas, S. R.; Schulz, E.; Shapira, O. M.; Vita, J. A.; Keaney, J. F., Jr. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J. Biol. Chem., 2004, 279 (45), 46637-46643.
151. Ndiaye, M.; Chataigneau, M.; Lobysheva, I.; Chataigneau, T.; Schini-Kerth, V. B. Red wine polyphenol-induced, endotheliumdependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NOsynthase in the isolated porcine coronary artery. FASEB J., 2005, 19 (3), 455-457.
152. Anter, E.; Chen, K.; Shapira, O. M.; Karas, R. H.; Keaney, J. F., Jr. p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. Circ. Res., 2005, 96 (10), 1072-1078.
153. Klinge, C. M.; Blankenship, K. A.; Risinger, K. E.; Bhatnagar, S.; Noisin, E. L.; Sumanasekera, W. K.; Zhao, L.; Brey, D. M.; Keynton, R. S. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J. Biol. Chem., 2005, 280 (9), 7460-7468.
154. Li, Y.; Ying, C.; Zuo, X.; Yi, H.; Yi, W.; Meng, Y.; Ikeda, K.; Ye, X.; Yamori, Y.; Sun, X. Green tea polyphenols down-regulate caveolin-1 expression via ERK1/2 and p38MAPK in endothelial cells. J. Nutr. Biochem., 2009, 20 (12), 1021-1027.
155. Wallerath, T.; Deckert, G.; Ternes, T.; Anderson, H.; Li, H.; Witte, K.; Forstermann, U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation, 2002, 106 (13), 1652-1658.
156. Wallerath, T.; Poleo, D.; Li, H.; Forstermann, U. Red wine increases the expression of human endothelial nitric oxide synthase: A mechanism that may contribute to its beneficial cardiovascular effects. J. Am. Coll. Cardiol., 2003, 41 (3), 471-478.
157. Stampfer, M. J.; Kang, J. H.; Chen, J.; Cherry, R.; Grodstein, F. Effects of moderate alcohol consumption on cognitive function in women. N. Engl. J. Med., 2005, 352 (3), 245-253.
158. Ferrero, M. E.; Bertelli, A. E.; Fulgenzi, A.; Pellegatta, F.; Corsi, M. M.; Bonfrate, M.; Ferrara, F.; De Caterina, R.; Giovannini, L.; Bertelli, A. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am. J. Clin. Nutr., 1998, 68 (6), 1208-1214.
159. Cordova, A. C.; Jackson, L. S.; Berke-Schlessel, D. W.; Sumpio, B. E. The cardiovascular protective effect of red wine. J. Am. Coll. Surg., 2005, 200 (3), 428-439.
160. Diebolt, M.; Bucher, B.; Andriantsitohaina, R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension, 2001, 38 (2), 159-165.
161. Shinmura, K.; Xuan, Y. T.; Tang, X. L.; Kodani, E.; Han, H.; Zhu, Y.; Bolli, R. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ. Res., 2002, 90 (5), 602-608.
162. Quinlan, P.; Lane, J.; Aspinall, L. Effects of hot tea, coffee and water ingestion on physiological responses and mood: The role of caffeine, water and beverage type. Psychopharmacology (Berl.), 1997, 134 (2), 164-173.
163. Anselm, E.; Chataigneau, M.; Ndiaye, M.; Chataigneau, T.; Schini-Kerth, V. B. Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src-and Akt-dependent activation of eNOS. Cardiovasc. Res., 2007, 73 (2), 404-413.
164. Dal-Ros, S.; Bronner, C.; Schott, C.; Kane, M. O.; Chataigneau, M.; Schini-Kerth, V. B.; Chataigneau, T. Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery. J. Pharmacol. Exp. Ther., 2009, 328 (2), 478-486.
165. Ndiaye, M.; Chataigneau, T.; Chataigneau, M.; Schini-Kerth, V. B. Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway. Br. J. Pharmacol., 2004, 142 (7), 1131-1136.
166. Actis-Goretta, L.; Ottaviani, J. I.; Fraga, C. G. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J. Agric. Food Chem., 2006, 54 (1), 229-234.
167. Duarte, J.; Perez Vizcaino, F.; Utrilla, P.; Jimenez, J.; Tamargo, J.; Zarzuelo, A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol., 1993, 24 (4), 857-862.
168. Perez-Vizcaino, F.; Ibarra, M.; Cogolludo, A. L.; Duarte, J.; Zaragoza-Arnaez, F.; Moreno, L.; Lopez-Lopez, G.; Tamargo, J. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J. Pharmacol. Exp. Ther., 2002, 302 (1), 66-72.
169. Corder, R.; Douthwaite, J. A.; Lees, D. M.; Khan, N. Q.; Viseu Dos Santos, A. C.; Wood, E. G.; Carrier, M. J. Endothelin-1 synthesis reduced by red wine. Nature, 2001, 414 (6866), 863-864.
170. Khan, N. Q.; Lees, D. M.; Douthwaite, J. A.; Carrier, M. J.; Corder, R. Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin. Sci. (Lond.), 2002, 103 Suppl. 48, 72S-75S.
171. Liu, J. C.; Chen, J. J.; Chan, P.; Cheng, C. F.; Cheng, T. H. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension, 2003, 42 (6), 1198-1205.
172. Aoi, W.; Niisato, N.; Miyazaki, H.; Marunaka, Y. Flavonoidinduced reduction of ENaC expression in the kidney of Dahl saltsensitive hypertensive rat. Biochem. Biophys. Res.Commun., 2004, 315 (4), 892-896.
173. Mackraj, I.; Govender, T.; Ramesar, S. The antihypertensive effects of quercetin in a salt-sensitive model of hypertension. J. Cardiovasc. Pharmacol., 2008, 51 (3), 239-245.
174. Armand, M.; Pasquier, B.; Andre, M.; Borel, P.; Senft, M.; Peyrot, J.; Salducci, J.; Portugal, H.; Jaussan, V.; Lairon, D. Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract. Am. J. Clin. Nutr., 1999, 70 (6), 1096-1106.
175. Koo, S. I.; Noh, S. K. Green tea as inhibitor of the intestinal absorption of lipids: Potential mechanism for its lipid-lowering effect. J. Nutr. Biochem., 2007, 18 (3), 179-183.
176. Shishikura, Y.; Khokhar, S.; Murray, B. S. Effects of tea polyphenols on emulsification of olive oil in a small intestine model system. J. Agric. Food Chem., 2006, 54 (5), 1906-1913.
177. Wang, S.; Noh, S. K.; Koo, S. I. Green tea catechins inhibit pancreatic phospholipase A(2) and intestinal absorption of lipids in ovariectomized rats. J. Nutr. Biochem., 2006, 17 (7), 492-498.
178. Conseil, G.; Baubichon-Cortay, H.; Dayan, G.; Jault, J. M.; Barron, D.; Di Pietro, A. Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP-and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. U. S. A., 1998, 95 (17), 9831-9836.
179. Leslie, E. M.; Mao, Q.; Oleschuk, C. J.; Deeley, R. G.; Cole, S. P. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol. Pharmacol., 2001, 59 (5), 1171-1180.
180. Ikeda, I.; Imasato, Y.; Sasaki, E.; Nakayama, M.; Nagao, H.; Takeo, T.; Yayabe, F.; Sugano, M. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim. Biophys. Acta, 1992, 1127 (2), 141-146.
181. Valsa, A. K.; Asha, S. K.; Vijayalakshmi, N. R. Effect of catechin on intestinal lipid metabolism. Indian. J. Physiol. Pharmacol., 1998, 42 (2), 286-290.
182. Pal, S.; Naissides, M.; Mamo, J. Polyphenolics and fat absorption. Int. J. Obes. Relat. Metab. Disord., 2004, 28 (2), 324-326.
183. Wilcox, L. J.; Borradaile, N. M.; de Dreu, L. E.; Huff, M. W. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J. Lipid Res., 2001, 42 (5), 725-734.
184. Whitman, S. C.; Kurowska, E. M.; Manthey, J. A.; Daugherty, A. Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages. Atherosclerosis, 2005, 178 (1), 25-32.
185. Abe, I.; Seki, T.; Umehara, K.; Miyase, T.; Noguchi, H.; Sakakibara, J.; Ono, T. Green tea polyphenols: Novel and potent inhibitors of squalene epoxidase. Biochem Biophys. Res. Commun., 2000, 268 (3), 767-771.
186. Borradaile, N. M.; de Dreu, L. E.; Wilcox, L. J.; Edwards, J. Y.; Huff, M. W. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem. J., 2002, 366 (Pt 2), 531-539.
187. Bursill, C.; Roach, P. D.; Bottema, C. D.; Pal, S. Green tea upregulates the low-density lipoprotein receptor through the sterolregulated element binding Protein in HepG2 liver cells. J. Agric. Food Chem., 2001, 49 (11), 5639-5645.
188. Pal, S.; Ho, N.; Santos, C.; Dubois, P.; Mamo, J.; Croft, K.; Allister, E. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells. J. Nutr., 2003, 133 (3), 700-706.
189. Baba, S.; Natsume, M.; Yasuda, A.; Nakamura, Y.; Tamura, T.; Osakabe, N.; Kanegae, M.; Kondo, K. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normoand hypercholesterolemic humans after intake of different levels of cocoa powder. J. Nutr., 2007, 137 (6), 1436-1441.
190. Baba, S.; Osakabe, N.; Kato, Y.; Natsume, M.; Yasuda, A.; Kido, T.; Fukuda, K.; Muto, Y.; Kondo, K. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDLcholesterol concentrations in humans. Am. J. Clin. Nutr., 2007, 85 (3), 709-717.
191. Mursu, J.; Voutilainen, S.; Nurmi, T.; Rissanen, T. H.; Virtanen, J. K.; Kaikkonen, J.; Nyyssonen, K.; Salonen, J. T. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic. Biol. Med., 2004, 37 (9), 1351-1359.
192. Lee, C. H.; Olson, P.; Evans, R. M. Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology, 2003, 144 (6), 2201-2207.
193. Alaynick, W. A. Nuclear receptors, mitochondria and lipid metabolism. Mitochondrion, 2008, 8 (4), 329-337.
194. Bookout, A. L.; Jeong, Y.; Downes, M.; Yu, R. T.; Evans, R. M.; Mangelsdorf, D. J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell, 2006, 126 (4), 789-799.
195. Forman, B. M.; Chen, J.; Evans, R. M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. U. S. A., 1997, 94 (9), 4312-4317.
196. Qiao, L.; Zou, C.; van der Westhuyzen, D. R.; Shao, J. Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes, 2008, 57 (7), 1824-1833.
197. van Bilsen, M.; van Nieuwenhoven, F. A. PPARs as therapeutic targets in cardiovascular disease. Expert Opin. Ther. Targets, 2010, 14 (10), 1029-1045.
198. Sharma, A. K.; Bharti, S.; Ojha, S.; Bhatia, J.; Kumar, N.; Ray, R.; Kumari, S.; Arya, D. S. Up-regulation of PPARgamma, heat shock protein-27 and-72 by naringin attenuates insulin resistance, betacell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br. J. Nutr., 2011, 106 (11), 1713-1723.
199. Wu, L. Y.; Juan, C. C.; Ho, L. T.; Hsu, Y. P.; Hwang, L. S. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J. Agric. Food Chem., 2004, 52 (3), 643-648.
200. Dulloo, A. G.; Seydoux, J.; Girardier, L.; Chantre, P.; Vandermander, J. Green tea and thermogenesis: Interactions between catechin-polyphenols, caffeine and sympathetic activity. Int. J. Obes. Relat. Metab. Disord., 2000, 24 (2), 252-258.
201. Dulloo, A. G.; Duret, C.; Rohrer, D.; Girardier, L.; Mensi, N.; Fathi, M.; Chantre, P.; Vandermander, J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr., 1999, 70 (6), 1040-1045.
202. Murase, T.; Nagasawa, A.; Suzuki, J.; Hase, T.; Tokimitsu, I. Beneficial effects of tea catechins on diet-induced obesity: Stimulation of lipid catabolism in the liver. Int. J. Obes. Relat. Metab. Disord., 2002, 26 (11), 1459-1464.
203. Mulvihill, E. E.; Allister, E. M.; Sutherland, B. G.; Telford, D. E.; Sawyez, C. G.; Edwards, J. Y.; Markle, J. M.; Hegele, R. A.; Huff, M. W. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes, 2009, 58 (10), 2198-2210.
204. Smith, R. M.; Tiesinga, J. J.; Shah, N.; Smith, J. A.; Jarett, L. Genistein inhibits insulin-stimulated glucose transport and decreases immunocytochemical labeling of GLUT4 carboxylterminus without affecting translocation of GLUT4 in isolated rat adipocytes: Additional evidence of GLUT4 activation by insulin. Arch. Biochem. Biophys., 1993, 300 (1), 238-246.
205. Vera, J. C.; Reyes, A. M.; Carcamo, J. G.; Velasquez, F. V.; Rivas, C. I.; Zhang, R. H.; Strobel, P.; Iribarren, R.; Scher, H. I.; Slebe, J. C.; Golde, D.W. Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1. J. Biol. Chem., 1996, 271 (15), 8719-8724.
206. Song, J.; Kwon, O.; Chen, S.; Daruwala, R.; Eck, P.; Park, J. B.; Levine, M. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and Glucose. J. Biol. Chem., 2002, 277 (18), 15252-15260.
207. Lekli, I.; Szabo, G.; Juhasz, B.; Das, S.; Das, M.; Varga, E.; Szendrei, L.; Gesztelyi, R.; Varadi, J.; Bak, I.; Das, D. K.; Tosaki, A. Protective mechanisms of resveratrol against ischemiareperfusion-induced damage in hearts obtained from Zucker obese rats: The role of GLUT-4 and endothelin. Am. J. Physiol. Heart Circ. Physiol., 2008, 294 (2), H859-866.
208. Nogowski, L.; Mackowiak, P.; Kandulska, K.; Szkudelski, T.; Nowak, K. W. Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann. Nutr. Metab., 1998, 42 (6), 360-366.
209. Kandulska, K.; Nogowski, L.; Szkudelski, T. Effect of some phytoestrogens on metabolism of rat adipocytes. Reprod. Nutr. Dev., 1999, 39 (4), 497-501.
210. Das, B.; Tandon, V.; Saha, N. Effects of phytochemicals of Flemingia vestita (Fabaceae) on glucose 6-phosphate dehydrogenase and enzymes of gluconeogenesis in a cestode (Raillietina echinobothrida). Comp. Biochem. Physiol. C. Toxicol. Pharmacol., 2004, 139 (1-3), 141-146.
211. Higashi, Y.; Noma, K.; Yoshizumi, M.; Kihara, Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ. J., 2009, 73 (3), 411-418.
212. Bonetti, P. O.; Lerman, L. O.; Lerman, A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol., 2003, 23 (2), 168-175.
213. Desideri, G.; Ferri, C. Endothelial activation. Sliding door to atherosclerosis. Curr. Pharm. Des., 2005, 11 (17), 2163-2175.
214. Sies, H.; Stahl, W.; Sevanian, A. Nutritional, dietary and postprandial oxidative stress. J. Nutr., 2005, 135 (5), 969-972.
215. Poli, G.; Leonarduzzi, G.; Biasi, F.; Chiarpotto, E. Oxidative stress and cell signalling. Curr. Med. Chem., 2004, 11 (9), 1163-1182.
216. Binsack, R.; Boersma, B. J.; Patel, R. P.; Kirk, M.; White, C. R.; Darley-Usmar, V.; Barnes, S.; Zhou, F.; Parks, D. A. Enhanced antioxidant activity after chlorination of quercetin by hypochlorous acid. Alcohol Clin. Exp. Res., 2001, 25 (3), 434-443.
217. Pannala, A. S.; Rice-Evans, C. A.; Halliwell, B.; Singh, S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem. Biophys. Res. Commun., 1997, 232 (1), 164-168.
218. Halliwell, B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol., 2006, 141 (2), 312-322.
219. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M. T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 2007, 39 (1), 44-84.
220. Siasos, G.; Tousoulis, D.; Antoniades, C.; Stefanadi, E.; Stefanadis, C. L-Arginine, the substrate for NO synthesis: An alternative treatment for premature atherosclerosis? Int. J. Cardiol., 2007, 116 (3), 300-308.
221. Forstermann, U.; Munzel, T. Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation, 2006, 113 (13), 1708-1714.
222. Tousoulis, D.; Boger, R. H.; Antoniades, C.; Siasos, G.; Stefanadi, E.; Stefanadis, C. Mechanisms of disease: L-arginine in coronary atherosclerosis-A clinical perspective. Nat. Clin. Pract. Cardiovasc. Med., 2007, 4 (5), 274-283.
223. Steffen, Y.; Gruber, C.; Schewe, T.; Sies, H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys., 2008, 469 (2), 209-219.
224. Vasquez-Martinez, Y.; Ohri, R. V.; Kenyon, V.; Holman, T. R.; Sepulveda-Boza, S. Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2. Bioorg. Med. Chem., 2007, 15 (23), 7408-7425.
225. Werz, O. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin. Planta Med., 2007, 73 (13), 1331-1357.
226. Mahesha, H. G.; Singh, S. A.; Rao, A. G. Inhibition of lipoxygenase by soy isoflavones: Evidence of isoflavones as redox inhibitors. Arch. Biochem. Biophys., 2007, 461 (2), 176-185.
227. Schewe, T.; Sadik, C.; Klotz, L. O.; Yoshimoto, T.; Kuhn, H.; Sies, H. Polyphenols of cocoa: Inhibition of mammalian 15-lipoxygenase. Biol. Chem., 2001, 382 (12), 1687-1696.
228. Sadik, C. D.; Sies, H.; Schewe, T. Inhibition of 15-lipoxygenases by flavonoids: Structure-activity relations and mode of action. Biochem. Pharmacol., 2003, 65 (5), 773-781.
229. Hancock, J. T. The role of redox in signal transduction. Methods Mol. Biol., 2008, 476, 1-9.
230. Jacob, C.; Giles, G. I.; Giles, N. M.; Sies, H. Sulfur and selenium: The role of oxidation state in protein structure and function. Angew. Chem. Int. Ed. Engl., 2003, 42 (39), 4742-4758.
231. Siasos, G.; Tousoulis, D.; Oikonomou, E.; Zaromitidou, M.; Stefanadis, C.; Papavassiliou, A. G. Inflammatory markers in hyperlipidemia: From experimental models to clinical practice. Curr. Pharm. Des., 2011, 17 (37), 4132-4146.
232. Aviram, M.; Rosenblat, M. Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J. Lipid Res., 1994, 35 (3), 385-398.
233. Fuhrman, B.; Aviram, M. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr. Opin. Lipidol., 2001, 12 (1), 41-48.
234. Siasos, G.; Tousoulis, D.; Kioufis, S.; Oikonomou, E.; Siasou, Z.; Limperi, M.; Papavassiliou, A. G.; Stefanadis, C. Inflammatory mechanisms in atherosclerosis: The impact of matrix metalloproteinases. Curr. Top. Med. Chem., 2012, 12 (10), 1132-1148.
235. Charakida, M.; Tousoulis, D.; Skoumas, I.; Pitsavos, C.; Vasiliadou, C.; Stefanadi, E.; Antoniades, C.; Latsios, G.; Siasos, G.; Stefanadis, C. Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia. Atherosclerosis, 2009, 204 (2), 532-537.
236. Tousoulis, D.; Papageorgiou, N.; Latsios, G.; Siasos, G.; Antoniades, C.; Stefanadis, C. C-reactive protein and endothelial dysfunction: Gazing at the coronaries. Int. J. Cardiol., 2011, 152 (1), 1-3.
237. Blake, G. J.; Ridker, P. M. Novel clinical markers of vascular wall inflammation. Circ. Res., 2001, 89 (9), 763-771.
238. McKellar, G. E.; McCarey, D. W.; Sattar, N.; McInnes, I. B. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat. Rev. Cardiol., 2009, 6 (6), 410-417.
239. Zeitler, H.; Ko, Y.; Zimmermann, C.; Nickenig, G.; Glanzer, K.; Walger, P.; Sachinidis, A.; Vetter, H. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Eur. J. Med. Res., 1997, 2 (9), 389-394.
240. Tousoulis, D.; Androulakis, E.; Papageorgiou, N.; Briasoulis, A.; Siasos, G.; Antoniades, C.; Stefanadis, C. From atherosclerosis to acute coronary syndromes: The role of soluble CD40 ligand. Trends Cardiovasc. Med., 2010, 20 (5), 153-164.
241. Kampoli, A. M.; Tousoulis, D.; Antoniades, C.; Siasos, G.; Stefanadis, C. Biomarkers of premature atherosclerosis. Trends Mol. Med., 2009, 15 (7), 323-332.
242. Chen, Y. C.; Shen, S. C.; Lee, W. R.; Hou, W. C.; Yang, L. L.; Lee, T. J. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J. Cell Biochem., 2001, 82 (4), 537-548.
243. Wadsworth, T. L.; Koop, D. R. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem. Biol. Interact., 2001, 137 (1), 43-58.
244. Boyle, J. J. Association of coronary plaque rupture and atherosclerotic inflammation. J. Pathol., 1997, 181 (1), 93-99.
245. Pignatelli, P.; Di Santo, S.; Buchetti, B.; Sanguigni, V.; Brunelli, A.; Violi, F. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: Effect on platelet recruitment. FASEB J., 2006, 20 (8), 1082-1089.
246. Furchgott, R. F.; Zawadzki, J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980, 288 (5789), 373-376.
247. Moe, G. W.; Rouleau, J. L.; Nguyen, Q. T.; Cernacek, P.; Stewart, D. J. Role of endothelins in congestive heart failure. Can. J. Physiol. Pharmacol., 2003, 81 (6), 588-597.
248. Touyz, R. M.; Schiffrin, E. L. Role of endothelin in human hypertension. Can. J. Physiol. Pharmacol., 2003, 81 (6), 533-541.
249. Stefanadi, E.; Tousoulis, D.; Androulakis, E. S.; Papageorgiou, N.; Charakida, M.; Siasos, G.; Tsioufis, C.; Stefanadis, C. Inflammatory markers in essential hypertension: Potential clinical implications. Curr. Vasc. Pharmacol., 2010, 8 (4), 509-516.
250. Siasos, G.; Tousoulis, D.; Siasou, Z.; Stefanadis, C.; Papavassiliou, A. G. Shear stress, protein kinases and atherosclerosis. Curr. Med. Chem., 2007, 14 (14), 1567-1572.
251. Siasos, G.; Tousoulis, D.; Vlachopoulos, C.; Antoniades, C.; Stefanadi, E.; Ioakeimidis, N.; Zisimos, K.; Siasou, Z.; Papavassiliou, A. G.; Stefanadis, C. The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance. Am. J. Hypertens., 2009, 22 (6), 586-592.
252. Oikonomou, E.; Tousoulis, D.; Siasos, G.; Zaromitidou, M.; Papavassiliou, A. G.; Stefanadis, C. The role of inflammation in heart failure: New therapeutic approaches. Hellenic J. Cardiol., 2011, 52 (1), 30-40.
253. Kannel, W. B. Risk stratification in hypertension: New insights from the Framingham Study. Am. J. Hypertens., 2000, 13 (1 Pt 2), 3S-10S.
254. D'Agostino, R. B., Sr.; Vasan, R. S.; Pencina, M. J.; Wolf, P. A.; Cobain, M.; Massaro, J. M.; Kannel, W. B. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation, 2008, 117 (6), 743-753.
255. Tousoulis, D.; Oikonomou, E.; Siasos, G.; Chrysohoou, C.; Charakida, M.; Trikas, A.; Siasou, Z.; Limperi, M.; Papadimitriou, E. D.; Papavassiliou, A. G.; Stefanadis, C. Predictive value of biomarkers in patients with heart failure. Curr. Med. Chem., 2012, 19 (16), 2534-2547.
256. Tousoulis, D.; Kampoli, A. M.; Siasos, G.; Stefanadi, E.; Antoniades, C.; Papavassiliou, A. G.; Stefanadis, C. Circulating biomarkers for the diagnosis and prognosis of heart failure. Curr. Med. Chem., 2009, 16 (29), 3828-3840.
257. Tousoulis, D.; Antoniades, C.; Nikolopoulou, A.; Koniari, K.; Vasiliadou, C.; Marinou, K.; Koumallos, N.; Papageorgiou, N.; Stefanadi, E.; Siasos, G.; Stefanadis, C. Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes. Eur. J. Clin. Invest., 2007, 37 (8), 623-628.
258. Xu, Y. C.; Leung, S. W.; Yeung, D. K.; Hu, L. H.; Chen, G. H.; Che, C. M.; Man, R. Y. Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery. Phytochemistry, 2007, 68 (8), 1179-1188.
259. Ajay, M.; Gilani, A. U.; Mustafa, M. R. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci., 2003, 74 (5), 603-612.
260. Cao, Y. X.; Yang, X. J.; Liu, J.; Li, K. X. Effects of daidzein sulfates on blood pressure and artery of rats. Basic Clin. Pharmacol. Toxicol., 2006, 99 (6), 425-430.
261. Papageorgiou, N.; Tousoulis, D.; Psaltopoulou, T.; Giolis, A.; Antoniades, C.; Tsiamis, E.; Miliou, A.; Toutouzas, K.; Siasos, G.; Stefanadis, C. Divergent anti-inflammatory effects of different oil acute consumption on healthy individuals. Eur. J. Clin. Nutr., 2011, 65 (4), 514-519.
262. Duarte, J.; Perez-Vizcaino, F.; Zarzuelo, A.; Jimenez, J.; Tamargo, J. Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur. J. Pharmacol., 1993, 239 (1-3), 1-7.
263. Li, W.; Du, L.; Li, M. Alkaloids and flavonoids as alpha(1)-adrenergic receptor antagonists. Curr. Med. Chem., 2011, 18 (32), 4923-4932.
264. Siasos, G.; Tousoulis, D.; Kollia, C.; Oikonomou, E.; Siasou, Z.; Stefanadis, C.; Papavassiliou, A. G. Adiponectin and cardiovascular disease: Mechanisms and new therapeutic approaches. Curr. Med. Chem., 2012, 19 (8), 1193-1209.
265. Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 2006, 116 (7), 1784-1792.
266. Kunimasa, K.; Kuranuki, S.; Matsuura, N.; Iwasaki, N.; Ikeda, M.; Ito, A.; Sashida, Y.; Mimaki, Y.; Yano, M.; Sato, M.; Igarashi, Y.; Oikawa, T. Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion. Bioorg. Med. Chem. Lett., 2009, 19 (7), 2062-2064.
267. Stote, K. S.; Clevidence, B. A.; Novotny, J. A.; Henderson, T.; Radecki, S. V.; Baer, D. J. Effect of cocoa and green tea on biomarkers of glucose regulation, oxidative stress, inflammation and hemostasis in obese adults at risk for insulin resistance. Eur. J. Clin. Nutr., 2012, 66 (10), 1153-1159.
268. Weseler, A. R.; Ruijters, E. J.; Drittij-Reijnders, M. J.; Reesink, K. D.; Haenen, G. R.; Bast, A. Pleiotropic benefit of monomeric and oligomeric flavanols on vascular health-A randomized controlled clinical pilot study. PLoS One, 2011, 6 (12), e28460.
269. Westphal, S.; Luley, C. Flavanol-rich cocoa ameliorates lipemiainduced endothelial dysfunction. Heart Vessels, 2011, 26 (5), 511-515.
270. de Pascual-Teresa, S.; Moreno, D. A.; Garcia-Viguera, C. Flavanols and anthocyanins in cardiovascular health: A review of current evidence. Int. J. Mol. Sci., 2010, 11 (4), 1679-1703.
271. Wang, C. Z.; Mehendale, S. R.; Calway, T.; Yuan, C. S. Botanical flavonoids on coronary heart disease. Am. J. Chin. Med., 2011, 39 (4), 661-671.
272. Dohadwala, M. M.; Holbrook, M.; Hamburg, N. M.; Shenouda, S. M.; Chung, W. B.; Titas, M.; Kluge, M. A.; Wang, N.; Palmisano, J.; Milbury, P. E.; Blumberg, J. B.; Vita, J. A. Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am. J. Clin. Nutr., 2011, 93 (5), 934-940.
273. Sirlak, M.; Akar, A. R.; Eryilmaz, S.; Cetinkanat, E. K.; Ozcinar, E.; Kaya, B.; Elhan, A. H.; Ozyurda, U. Micronized purified flavonoid fraction in pretreating CABG patients. Tex. Heart Inst. J., 2010, 37 (2), 172-177.
274. Arranz, S.; Chiva-Blanch, G.; Valderas-Martinez, P.; Medina-Remon, A.; Lamuela-Raventos, R. M.; Estruch, R. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients, 2012, 4 (7), 759-781.
275. Asher, G. N.; Viera, A. J.; Weaver, M. A.; Dominik, R.; Caughey, M.; Hinderliter, A. L. Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: A randomized, controlled cross-over trial. BMC Complement Altern. Med., 2012, 12, 26.
276. Opie, L. H.; Lecour, S. The red wine hypothesis: From concepts to protective signalling molecules. Eur. Heart J., 2007, 28 (14), 1683-1693.
277. Song, Y. H.; Cai, H.; Gu, N.; Qian, C. F.; Cao, S. P.; Zhao, Z. M. Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure. J. Pharm. Pharmacol., 2011, 63 (4), 541-549.
278. Tang, J. S.; Hou, Y. L.; Gao, H.; Chen, X.; Sun, S. C.; Guo, T. Z.; Kobayashi, H.; Ye, W. C.; Yao, X. S. Polyphenols from Parabarium huaitingii and their positive inotropic and antimyocardial infarction effects in rats. Phytomedicine, 2011, 18 (7), 544-550.
279. Li, G. R.; Wang, H. B.; Qin, G. W.; Jin, M. W.; Tang, Q.; Sun, H. Y.; Du, X. L.; Deng, X. L.; Zhang, X. H.; Chen, J. B.; Chen, L.; Xu, X. H.; Cheng, L. C.; Chiu, S. W.; Tse, H. F.; Vanhoutte, P. M.; Lau, C. P. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. Circulation, 2008, 117 (19), 2449-2457.
280. Zhao, G.; Gao, H.; Qiu, J.; Lu, W.; Wei, X. The molecular mechanism of protective effects of grape seed proanthocyanidin extract on reperfusion arrhythmias in rats in vivo. Biol. Pharm. Bull., 2010, 33 (5), 759-767.
281. Lagiou, P.; Samoli, E.; Lagiou, A.; Skalkidis, Y.; Katsouyanni, K.; Petridou, E.; Trichopoulos, D. Flavonoid classes and risk of peripheral arterial occlusive disease: A case-control study in Greece. Eur. J. Clin. Nutr., 2006, 60 (2), 214-219.
282. Dahmer, S.; Scott, E. Health effects of hawthorn. Am. Fam. Physician, 2010, 81 (4), 465-468.
283. Flammer, A. J.; Sudano, I.; Wolfrum, M.; Thomas, R.; Enseleit, F.; Periat, D.; Kaiser, P.; Hirt, A.; Hermann, M.; Serafini, M.; Leveques, A.; Luscher, T. F.; Ruschitzka, F.; Noll, G.; Corti, R. Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. Eur. Heart J., 2012, 33 (17), 2172-2180.
284. Tousoulis, D.; Zisimos, K.; Antoniades, C.; Stefanadi, E.; Siasos, G.; Tsioufis, C.; Papageorgiou, N.; Vavouranakis, E.; Vlachopoulos, C.; Stefanadis, C. Oxidative stress and inflammatory process in patients with atrial fibrillation: The role of left atrium distension. Int. J. Cardiol., 2009, 136 (3), 258-262.
285. Lee, Y. M.; Cheng, P. Y.; Chen, S. Y.; Chung, M. T.; Sheu, J. R. Wogonin suppresses arrhythmias, inflammatory responses, and apoptosis induced by myocardial ischemia/reperfusion in rats. J. Cardiovasc. Pharmacol., 2011, 58 (2), 133-142.
286. Garg, A.; Haffner, S. M. Insulin resistance and atherosclerosis. Diabetes Care, 1996, 19 (3), 274.
287. Ginsberg, H. N.; Huang, L. S. The insulin resistance syndrome: Impact on lipoprotein metabolism and atherothrombosis. J. Cardiovasc. Risk, 2000, 7 (5), 325-331.
288. Ginsberg, H. N.; Zhang, Y. L.; Hernandez-Ono, A. Metabolic syndrome: Focus on dyslipidemia. Obesity (Silver Spring), 2006, 14 Suppl. 1, 41S-49S.
289. Antoniades, C.; Tousoulis, D.; Marinou, K.; Papageorgiou, N.; Bosinakou, E.; Tsioufis, C.; Stefanadi, E.; Latsios, G.; Tentolouris, C.; Siasos, G.; Stefanadis, C. Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. Clin. Cardiol., 2007, 30 (6), 295-300.
290. Cassidy, A.; Mukamal, K. J.; Liu, L.; Franz, M.; Eliassen, A. H.; Rimm, E. B. High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation, 2013, 127 (2), 188-196.
291. Ajdzanovic, V. Z.; Milosevic, V.; Spasojevic, I. B. Glucocorticoid excess and disturbed hemodynamics in advanced age: The extent to which soy isoflavones may be beneficial. Gen. Physiol. Biophys., 2012, 31 (4), 367-374.
292. Wright, B.; Spencer, J. P.; Lovegrove, J. A.; Gibbins, J. M. Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs. Cardiovasc. Res., 2013, 97 (1), 13-22.
293. Jennings, A.; Welch, A. A.; Fairweather-Tait, S. J.; Kay, C.; Minihane, A. M.; Chowienczyk, P.; Jiang, B.; Cecelja, M.; Spector, T.; Macgregor, A.; Cassidy, A. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am. J. Clin. Nutr., 2012, 96 (4), 781-788.
294. Mitjavila, M. T.; Moreno, J. J. The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases. Biochem. Pharmacol., 2012, 84 (9), 1113-1122.
295. Zhou, Z.; Nair, M. G.; Claycombe, K. J. Synergistic inhibition of interleukin-6 production in adipose stem cells by tart cherry anthocyanins and atorvastatin. Phytomedicine, 2012, 19 (10), 878-881.
296. Kleinedler, J. J.; Foley, J. D.; Alexander, J. S.; Roerig, S. C.; Hebert, V. Y.; Dugas, T. R. Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices. J. Biomed. Mater. Res. B Appl. Biomater., 2011, 99 (2), 266-275.
297. Aftab, N.; Vieira, A. Antioxidant activities of curcumin and combinations of this curcuminoid with other phytochemicals. Phytother. Res., 2010, 24 (4), 500-502.
298. Dai, F.; Chen, W. F.; Zhou, B. Antioxidant synergism of green tea polyphenols with alpha-tocopherol and L-ascorbic acid in SDS micelles. Biochimie, 2008, 90 (10), 1499-1505.
299. de Morais, E. C.; Stefanuto, A.; Klein, G. A.; Boaventura, B. C.; de Andrade, F.; Wazlawik, E.; Di Pietro, P. F.; Maraschin, M.; da Silva, E. L. Consumption of yerba mate (Ilex paraguariensis) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy. J. Agric. Food Chem., 2009, 57 (18), 8316-8324.
300. Kwon, E. K.; Lee, D. Y.; Lee, H.; Kim, D. O.; Baek, N. I.; Kim, Y. E.; Kim, H. Y. Flavonoids from the buds of Rosa damascena inhibit the activity of 3-hydroxy-3-methylglutaryl-coenzyme a reductase and angiotensin I-converting enzyme. J. Agric. Food Chem., 2010, 58 (2), 882-886.
301. Panda, S.; Kar, A.; Banerjee, T.; Sharma, N. Combined effects of quercetin and atenolol in reducing isoproterenol-induced cardiotoxicity in rats: Possible mediation through scavenging free radicals. Cardiovasc. Toxicol., 2012, 12 (3), 235-242.
302. Pietrocola, F.; Marino, G.; Lissa, D.; Vacchelli, E.; Malik, S. A.; Niso-Santano, M.; Zamzami, N.; Galluzzi, L.; Maiuri, M. C.; Kroemer, G. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle, 2012, 11 (20), 3851-3860.
303. Rodrigo, R.; Gil, D.; Miranda-Merchak, A.; Kalantzidis, G. Antihypertensive role of polyphenols. Adv. Clin. Chem., 2012, 58, 225-254.
304. Frombaum, M.; Le Clanche, S.; Bonnefont-Rousselot, D.; Borderie, D. Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: Potential benefits to cardiovascular diseases. Biochimie, 2012, 94 (2), 269-276.
305. Nishizuka, T.; Fujita, Y.; Sato, Y.; Nakano, A.; Kakino, A.; Ohshima, S.; Kanda, T.; Yoshimoto, R.; Sawamura, T. Procyanidins are potent inhibitors of LOX-1: A new player in the French Paradox. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 2011, 87 (3), 104-113.
306. Prasain, J. K.; Carlson, S. H.; Wyss, J. M. Flavonoids and agerelated disease: Risk, benefits and critical windows. Maturitas, 2010, 66 (2), 163-171.
307. Kyselova, Z. Toxicological aspects of the use of phenolic compounds in disease prevention. Interdiscip. Toxicol., 2011, 4 (4), 173-183.